Admission for and mortality from primary venous thromboembolism in women of fertile age in Denmark, 1977-95

British Medical Journal

Volumn 319, Issue 7213, 1999, Pages 820-821

  Mellemkjær, Lene ^a   Sørensen, Henrik Toft ^b   Dreyer, Lene ^a   Olsen, Jørn ^c   Olsen, Jørgen H ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF AARHUS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; DENMARK; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0033604083     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7213.820     Document Type: Article

References (5)

1. World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multi-centre case-control study. Lancet 1995; 846;1575-82
2. Jick H. Jick S. Gurewich V, Myers M, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestogen components. Lancet 1995;346:1589-93.
3. Spitzer W, Lewis M, Herinemann L, Thorogood M, MacRac K. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. BMJ 1996;312:83-8.
4. Vandenbroucke J, Bloemenkamp K, Helmerhorst F, Rosendaal F. Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands. Lancet 1996;348:401-2.
5. Thomas S. Mortality from venous thromboembolism and myocardial infarction in young adults in England and Wales. Lancet 1996;348:102.